Leveraging Evolutionary Trade-Offs and Phage Selection Pressure to Reduce Bacterial Pathogenicity

Leveraging Evolutionary Trade-Offs and Phage Selection Pressure to Reduce Bacterial Pathogenicity

EvoEcoSeminars via YouTube Direct link

Trade-ups WOULD NOT benefit phage therapy

12 of 15

12 of 15

Trade-ups WOULD NOT benefit phage therapy

Class Central Classrooms beta

YouTube videos curated by Class Central.

Classroom Contents

Leveraging Evolutionary Trade-Offs and Phage Selection Pressure to Reduce Bacterial Pathogenicity

Automatically move to the next video in the Classroom when playback concludes

  1. 1 Intro
  2. 2 Leveraging evolutionary trade-offs and phage selection pressure to reduce bacterial pathogenicity
  3. 3 Phage therapy: a renewed approach
  4. 4 Isolating phage candidates
  5. 5 Incorporating genome sequencing
  6. 6 Measuring phage host-range
  7. 7 Characterizing phage binding
  8. 8 Trade-offs WOULD benefit phage therapy
  9. 9 Identify phages that drive antibiotic resistance trade-offs
  10. 10 Determine likelihood that mutations cause trade-offs
  11. 11 Identify phages that drive virulence trade-offs
  12. 12 Trade-ups WOULD NOT benefit phage therapy
  13. 13 Case 1: Emergency phage therapy in human volunteer
  14. 14 Examining clinical samples pre- vs. post-therapy
  15. 15 Evolutionary prediction

Never Stop Learning.

Get personalized course recommendations, track subjects and courses with reminders, and more.

Someone learning on their laptop while sitting on the floor.